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Synopsis.
OBJECTIVES: Physical appearance has significant importance psy-
chologically and socially, with skin and hair being of prime rele-
vance. Effective ingredients that modulate melanin synthesis are of
growing interest. Tamoxifen, a widely used selective oestrogen
receptor modulator, SERM, was described occasionally in medical
case reports as causing grey hair repigmentation. This work aimed
to study, in vitro, the effect of tamoxifen and 4-hydroxy-tamoxifen,
one of its most bioactive derivatives, on melanin production in
human melanocytes.
METHODS: Adult normal human epidermal melanocytes (NHEM)
were treated with physiological concentrations of tamoxifen and 4-
hydroxy-tamoxifen during 72 hours. Cytotoxicity was evaluated by
lactate dehydrogenase (LDH) leakage. Total melanin was quantified
by spectrophotometry, and cyclic adenosine monophosphate
(cAMP) was determined by competitive ELISA. The relative mRNA
levels of several genes involved in melanogenesis were investigated
by real-time PCR.
RESULTS: Under the conditions used, the results showed that
tamoxifen and 4-hydroxy-tamoxifen treatments, none of them toxic
to NHEM, induced a time-dependent increase in the amount of mel-
anin released to the culture medium. cAMP, one of the major sec-
ond messenger in signalling pathways important to melanogenesis,
was decreased after treatment. The transcript levels of genes coding
for catalase, premelanosome protein and melan-A, directly related
to skin and hair pigmentation, showed an increased tendency upon
tamoxifen and 4-hydroxy-tamoxifen treatment. Induction of cata-
lase gene expression in NHEM points towards a promelanogenic
effect mediated by ROS.
CONCLUSION: According to the results, even in such a short treat-
ment period, tamoxifen and 4-hydroxy-tamoxifen promoted melanin
extrusion and they seem to act as melanogenesis stimulators at the
molecular level. Our data suggest that SERMs might be a new tool
for increasing melanogenesis and might be of great interest for topi-
cal formulations in cosmetic industry.
Resume.
OBJECTIF: L’apparence physique a une grande importance psycho-
logique et sociale, la peau et les cheveux etant d’un intere^t primor-
dial. Les ingredients efficaces qui modulent la synthese de melanine
sont d’un intere^t croissant. Le tamoxifene, un modulateur selectif
des recepteurs d’oestrogene largement utilise (SERM), a ete decrit
dans les rapports de cas medicaux comme causant une re-pigmenta-
tion des cheveux gris. Ce travail visait a etudier, in vitro, l’effet du
tamoxifene et du 4-hydroxy-tamoxifene, un de ses derives les plus
bioactifs, sur la production de melanine dans les melanocytes de
l’homme.
METHODES: Des melanocytes epidermiques adulte humains norm-
aux (NHEM) ont ete traites avec des concentrations physiologiques
de tamoxifene et de 4-hydroxy-tamoxifene pendant 72 heures. La
cytotoxicite a ete evaluee par la secretion de la lactate-deshy-
drogenase (LDH). La melanine totale a ete quantifiee par spectro-
photometrie et l’adenosine monophosphate cyclique (AMPc) a ete
determinee par ELISA. Les niveaux relatifs d’ARNm de plusieurs
genes impliques dans la melanogenese ont ete etudies par PCR en
temps reel.
RESULTATS: Dans les conditions utilisees, les resultats ont montre
que les traitements au tamoxifene et au 4-hydroxy-tamoxifene, au-
cun d’entre eux n’etant toxique pour les NHEM, induisent une aug-
mentation en fonction du temps, de la quantite de melanine liberee
dans le milieu de culture. L’AMPc, un des messagers secondaires
importants dans les voies de signalisation principales de la mela-
nogenese, a diminue apres le traitement. Les niveaux de transcrip-
tion des genes codant pour la catalase, la proteine pre-melanosome
et melan-A, directement liees a la pigmentation de la peau et des
cheveux, ont montre une tendance a l’augmentation par le tamox-
ifene et le 4-hydroxy-tamoxifene. L’induction de l’expression du
gene de la catalase dans les NHEM pointe vers un effet pro-mela-
nogenique medie par les ROS.
CONCLUSION: Selon les resultats, me^me dans une periode de trait-
ement de courte duree, le tamoxifene et le 4-hydroxy-tamoxifene
promeuvent l’extrusion de la melanine et ils semblent agir comme
stimulateurs de la melanogenese au niveau moleculaire. Nos
donnees suggerent que les SERMs pourraient devenir un nouvel
outil pour augmenter la melanogenese et peut-e^tre avoir un grand
intere^t pour les formulations topiques dans l’industrie cosmetique.
Introduction
In today’s society, the concern with preserving a good physical
appearance feeds a huge industry of cosmetic products, with skin
and its appendages (hair in particular) being the primary targets.
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Oestrogens play important protective roles in skin physiology
and ageing [1]. They accelerate wound healing, improve inflamma-
tory skin conditions and provide protection to skin photoageing
[2]. The beneficial effects are confirmed by the changes seen in
post-menopausal women when a rapid skin age-related deteriora-
tion is observed – thinner and drier skin, more and deeper wrin-
kles, loss of skin firmness and elasticity [2]. Topical application of
oestrogens and hormonal replacement therapies can reverse at
some extent these skin age-related events. The effect of oestrogens
in human hair cycle is not so obvious; they appear to stimulate
hair growth by decreasing the resting phase and by prolonging the
anagen phase, especially in women; it was demonstrated that oes-
trogen has the ability to modify androgen metabolism in dermal
papillae of hair follicles [3]. Oestrogens also affect skin pigmenta-
tion. High oestrogen levels are associated with an increase in skin
pigmentation particularly evident during pregnancy and during the
use of oestrogen-containing oral contraceptives. Topical application
of oestrogens was described as having no significant effect on pig-
mentary changes in aged skin [4]. In in vitro studies, some appar-
ent conflicting reports have been published; McLeod et al. [5]
reported that melanocytes respond to oestrogens, in particular to
17b-oestradiol, with increased melanin production and extrusion,
whereas Jee et al. [6] reported an increase in melanocyte prolifera-
tion with a concomitant decrease in melanin levels and tyrosinase
activity. More, recently, it was demonstrated in vitro that the oes-
trogen receptor a is an activator of dopachrome tautomerase gene
(DCT) promoter activity in cooperation with additional transcription
factors and microphthalmia-associated transcription factor (MITF)
in normal human melanocytes [7].
Since the discovery in the 1990s that skin expresses oestrogen
receptors that decline in number from the onset of menopause, the
search for safe and effective alternatives with more focused effects
on the skin, topical oestrogens, phyto-oestrogens and tissue-specific
drugs called selective oestrogen receptor modulators (SERMs) has
been explored [8, 9]. SERMs bind to oestrogen receptors and can
act as either oestrogen agonists or antagonists depending on the
target tissue. Tamoxifen, a non-steroidal triphenylethylene, is a
SERM widely used, since 1971, in the management of women with
all stages hormone-responsive breast cancer [10]. Although the
effects of oestrogens on skin are extensively documented, there are
very limited data on the effect of SERMs on this organ. Topical
tamoxifen improves the appearance of keloid scars in acute burns
patients, fading fibroblast proliferation and collagen synthesis [1].
SERMs tamoxifen, raloxifene and genistein all substantially benefit
skin healing in the oestrogen-deprived ovariectomized mouse, most
likely mediated via oestrogen receptor b [1]. In contrast, a subcuta-
neous administration of tamoxifen in rat resulted in the appearance
of abnormal hair follicles, epidermal atrophy and increased dermal
fibrosis, particularly around the hair follicles; in humans, there
have been reports of tamoxifen treatment causing diffuse thinning
of the hair with moderate receding of the frontal hair line and the
development of alopecia on the crown; in organ culture, tamoxifen
alone has no effect on human hair shaft elongation, whereas in
excess tamoxifen in combination with 17b-oestradiol eliminated
the effect of 17b-oestradiol, suggesting that tamoxifen can function
as an antagonist of oestrogen in the scalp hair follicle [2]. Tamoxi-
fen has also been described as causing repigmentation of a 68-
year-old breast cancer patient’s grey hair [11]. So far, the available
literature points to the ability of SERMs acting as oestrogen agon-
ists in skin, being able to control skin ageing, wound healing and
scarring and to their potential use in topical formulations that
would avoid the harmful effects associated with systemic hormone
replacement therapies [8].
Along with the beneficial effects of SERMs already described on
skin healing and ageing, it would be of great interest to ascertain
their effects on skin pigmentation. Melanogenesis is a defensive
mechanism against excessive exposure of human skin to sunlight,
an environmental risk factor for melanoma and skin ageing. This
work aims to study, in vitro, the effect on melanin production of
tamoxifen and 4-hydroxy-tamoxifen, one of its most bioactive
derivatives and to contribute to a more complete understanding of
the potential cosmetic use of this SERM.
Materials and methods
Reagents
Tamoxifen (Tam) and 4-hydroxy-tamoxifen (4HO-Tam), reduced
disodium salt hydrate b-nicotinamide adenine dinucleotide (NADH),
sodium pyruvate, melanin from Sepia officinalis and Trypsin–EDTA
solution were purchased from Sigma-Aldrich Chemie GmbH (Buchs,
Switzerland). Soluene-350 was obtained from PerkinElmer (Wal-
tham, MA, U.S.A.). Absolute ethanol (EtOH) used as solvent for Tam
and 4HO-Tam, as well as other common chemical reagents used to
prepare the buffers, was purchased from Panreac (Barcelona, Spain).
Cells and culture conditions
Adult normal human epidermal melanocytes (NHEM) and the opti-
mized media for their growth were supplied by Lonza (Lonza Walk-
ersville, Inc, Walkersville, MD, U.S.A.). Cells were maintained in
Melanocyte Cell Basal Medium-4 supplemented with calcium chlo-
ride, bovine pituitary extract, recombinant human fibroblast
growth factor-B, recombinant human insulin, hydrocortisone,
phorbol 12-myristate 13-acetate, gentamicin sulphate and ampho-
tericin-B, foetal bovine serum (melanocyte growth medium 4,
MGM-4) and endothelin-3 according to the supplier’s instructions.
Cell culture was established and maintained in 25 cm2 flasks at
37°C and 5% CO2 in a humidified incubator with the recom-
mended starting cell density of 10 000 cells cm2.
NHEM treatment with tamoxifen and 4-hydroxy-tamoxifen
Normal human epidermal melanocytes were treated with physiolog-
ical concentrations of the drugs. Two days after seeding passage 3,
melanocytes were incubated with 1 lM Tam and 0.5 lM 4HO-
Tam for 72 h. As controls, melanocytes without any treatment and
melanocytes incubated with 0.1% EtOH were plated in parallel. The
media was refreshed every 24 h and collected for further analysis.
Total melanin spectrophotometric evaluation
The melanin content was quantified with either 300 000 cells, pla-
ted on Petri dishes (∅60 mm), or from the culture media collected
at 24 h, 48 h and 72 h. For measuring intracellular melanin, cells
were detached and disrupted in one millilitre of 15 mM Tris–HCl
lysis solution, pH 7.5. A 150 lL of either cell lysate or cell culture
medium was solubilized in 1350 lL of Soluene-350 at 80°C for
1 h. The calibration curves were obtained by solubilizing 5, 10,
20, 30, 40, 60, 80, 100, 300 and 500 mg of Sepia melanin in Sol-
uene-350 with 10% Tris–HCl or culture medium, depending on
sample type, at 80°C for 1 h [12, 13]. Before measuring the absor-
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International Journal of Cosmetic Science, 1–7
In vitro effect of tamoxifen on cutaneous melanogenesis T. Matama et al.
bance at 500 nm, samples and standards were centrifuged for
10 min at 8600 g.
Cytotoxicity evaluation
The cytotoxicity induced by Tam and 4HO-Tam at the tested con-
centrations was evaluated by lactate dehydrogenase (LDH) release
to the culture medium simultaneously to extruded melanin moni-
toring. The LDH activity was determined by the decrease in NADH
absorbance at 340 nm during 3 min at 30°C, using a microplate
reader. The final reaction volume was 300 lL consisting in
250 lM NADH and 280 lM pyruvate in 50 mM phosphate buffer,
pH 7.4. To measure the intra- and extracellular LDH activity,
45 lL of NHEM lysate and 90 lL of culture medium were used,
respectively. The percentage of LDH release was expressed as the
relation between extracellular activity and total LDH activity.
Determination of cyclic adenosine monophosphate levels
To assess how NHEM treatment with Tam and 4HO-Tam affects
the levels of cytoplasmic cyclic adenosine monophosphate (cAMP),
145 000 cells were seeded on 6-well plates and treated as
described. After 72 h, cells were collected in 300 lL of 100 mM
HCl solution. Cyclic AMP was quantified using a commercial com-
petitive enzyme-linked immunosorbent assay (Cayman Chemical,
Ann Arbor, MI, U.S.A.).
Relative gene expression levels determined by real-time PCR
Total RNA was isolated from 55 500 melanocytes, cultured in 12-
well plates and treated with Tam and 4HO-Tam as described
before, using the SV Total RNA Isolation System (Promega Corpo-
ration, Fitchburg WI, U.S.A.) according to the manufacturer’s
instructions. Reverse transcription (RT) was performed with iScript
cDNA Synthesis kit (Bio-Rad Laboratories, Lda., Amadora, Portu-
gal), according to the supplied protocol. The reaction was carried
out at 25°C for 5 min, 42°C for 60 min and 85°C for 5 min. Real-
time PCR was used to determine whether Tam/4HO-Tam were able
to affect the expression of catalase gene and several genes overex-
pressed in human pigmented hair follicles when compared with
grey hair follicles (unpublished results). TaqMan Universal Master
Mix II and the pre-designed/pre-formulated primer and probe sets,
TaqMan Gene Expression Assays (Table I), were purchased from
Applied Biosystems (Foster City, CA, U.S.A.), and the DDCt method
was applied using as housekeeping gene, the mitochondrial ATPase
6 (MT-ATP6). The PCR amplification was performed according to
the manufacturer’s instructions on an CFX96 Touch Real-Time
PCR Detection System (Bio-Rad Laboratories, Lda.).
Statistical analysis
The data were expressed as the mean  SEM of at least five repli-
cates. A nonparametric analysis was performed: Kruskal–Wallis
H-test or Friedman test for repeated measures along time. When
P-values were equal or inferior to 0.05, the differences were consid-
ered significant. Whenever the Kruskal–Wallis H-test led to signifi-
cant results, Mann–Whitney U-test was performed for sample
contrasts between individual sample sets at 0.05 level of risk. All
the statistical analysis was performed using Minitab 16 version
16.1.0 ( Minitab Inc., State College, PA, U.S.A.).
Results and discussion
In the present work, we studied the effect of tamoxifen and 4-
hydroxy-tamoxifen on melanin production. For this purpose, nor-
mal human epidermal melanocytes (NHEM) were incubated with
0.1% (v/v) ethanol solutions of tamoxifen (Tam) and 4-hydroxy-
tamoxifen (4HO-Tam) at concentrations in physiological range as
determined in patients’ serum under tamoxifen treatment [14]. The
cells were exposed during three days with medium renewal every
24 h. Total melanin was quantified by spectrophotometry. After
performing a calibration curve, the average intracellular melanin
content of control NT after 72 h was determined as 540 ng lg1
of protein. The obtained results were expressed as a ratio of nor-
malized melanin amount having the control NT as divisor (Fig. 1).
A trend was observed in the amount of intracellular melanin;
melanocytes exposed to Tam and 4HO-Tam produced significantly
more melanin than the controls, although ethanol alone (Control
Table I List of TaqMan assays used and respective targets of amplification
TaqMan assay Gene symbol Protein name Function (GeneCards)
Hs00156308_m1 CAT Catalase Protection of cells from the toxic effects of hydrogen peroxide
Hs00167051_m1 TYRP1 Tyrosinase-related protein 1 Melanosomal enzyme that belongs to the tyrosinase family and plays an important role in
the melanin biosynthetic pathway
Hs00173854_m1 SILV Premelanosome protein Melanocyte-specific type I transmembrane glycoprotein (PMEL17) involved in the maturation
of melanosomes from stage I to II
Hs00194133_m1 MLANA Melan-A (MART-1) Vital role in the expression, stability, trafficking and processing of melanocyte protein
PMEL17
Hs01385410_m1 SLC24A5 Solute carrier family 24, member 5 Cation exchanger involved in pigmentation, possibly by participating in ion transport in
melanosomes
Hs01099965_m1 TYR Tyrosinase Copper-containing oxidase that functions in the formation of pigments such as melanins
and other polyphenolic compounds
Hs00174029_m1 KIT v-kit Hardy–Zuckerman 4 feline
sarcoma viral oncogene homolog
Type 3 transmembrane receptor for MGF (mast cell growth factor, also known as stem
cell factor)
Hs00955621_m1 PLXNC1 Plexin C1 Transmembrane receptors for semaphorins together they regulate melanocyte adhesion
Hs02596862_g1 MT-ATP6 Mitochondrially encoded ATP
synthase 6
© 2013 John Wiley & Sons Ltd 3
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EtOH) was able to induce melanogenesis, to a smaller extent, under
this experimental conditions. In a genome-wide siRNA-based func-
tional genomics study of pigmentation, unexpected genes were
found to support pigment production through tyrosinase expression
and stability [15]. Two of those genes encode two isoforms of alde-
hyde dehydrogenase, ALDH1A1 and ALDH9A1, which regulate
ethanol detoxification. Non-toxic chemical inhibitors of the two
ALDH enzymes inhibited pigmentation and tyrosinase protein accu-
mulation in MNT-1 cells, and they impaired UV-induced tyrosinase
expression when tested in primary melanocytes [15]. On the other
hand, the amount of ethanol solvent present in cell culture med-
ium could promote the activity of these detoxifying enzymes and
promote melanogenesis in NHEM (Fig. 1).
Skin pigmentation is the result of two major events: the synthe-
sis of melanin by melanocytes and the transfer of melanosomes to
the surrounding keratinocytes [16]. Thus, for its biological rele-
vance, melanin extrusion was also evaluated during the incubation
of NHEM with Tam and 4HO-Tam (Fig. 2). The results obtained
revealed a significant kinetic effect of Tam and mainly 4HO-Tam
on melanin extrusion by NHEM. Note that 4HO-Tam accelerated
melanin extrusion in the first 24 h, although these levels became
similar in all conditions at 48 h and 72 h.
In normal human cultured melanocytes, physiological concen-
trations of oestrogens, especially 17b-oestradiol, were described as
enhancers of melanin production (1.25-fold increase) and extrusion
(3.4-fold increase after 16 h) [5]. The authors also tested the ste-
roid anti-oestrogen ICI 164 384, and they verified that in melano-
cytes, it also increased tyrosinase activity, behaving as an
oestrogen agonist. In the experiment performed, it becomes appar-
ent that Tam and particularly 4HO-Tam behave as oestrogen agon-
ists in NHEM by promoting both melanogenesis and melanin
extrusion. The fact that the MGM-4 medium was supplemented
with endothelin-3 to enhance the proliferative capacity of melano-
cyte cultures through serial passages, according to manufacturer
instructions, may have diluted the additive response of cells to Tam
and 4HO-Tam because the basal levels of control were raised by
this hormone (data not shown) [17]. On the other hand, the pro-
melanogenesis effect of tamoxifen may be a long-term effect as
reported for the repigmentation of a 68-year-old breast cancer
patient’s grey hair after two years of tamoxifen treatment [11].
Cell viability was monitored by evaluating cell membrane perme-
ability. The amount of lactate dehydrogenase (LDH) released into
the medium was determined in terms of its enzymatic activity and
related to the activity in the medium of non-treated (NT) NHEM,
after the first 24 h of incubations (Fig. 3). In all the treatments,
the LDH release was under 5% during the assay period. As
expected, the amount of LDH leakage revealed that Tam and 4HO-
Tam had no significant cytotoxic effect at the tested concentrations.
Another control was performed bearing the same solvent concen-
Figure 1 Intracellular melanin after 72 h of incubation of NHEM with
tamoxifen (Tam) and 4-hydroxy-tamoxifen (4HO-Tam) normalized to the
total amount of protein and expressed as fold change in melanin in relation
to the non-treated (NT) control. The effect of the solvent alone (control
EtOH) is also shown. Averages that do not share a letter are significantly dif-
ferent according to Kruskal–Wallis H-test (H = 8.07; DF = 3; P = 0.045) fol-
lowed by Mann–Whitney U-test as post-hoc test.
Figure 2 Melanin extruded to the culture medium by NHEM during the
incubation with tamoxifen (Tam) and 4-hydroxy-tamoxifen (4HO-Tam); the
values are expressed as fold change in relation to melanin levels in non-trea-
ted (NT) control after 24 h. The effect of the solvent alone (control EtOH) is
also shown. (Friedman test – extruded melanin vs. time grouped by treat-
ment, S = 6.00; DF = 2; P = 0.050).
Figure 3 Lactate dehydrogenase (LDH) released into the NHEM culture
medium determined as a percentage ratio of enzyme activities. The LDH
activity is expressed in relation to the untreated (NT) control after the first
24 h of the experiment. The effect of the solvent alone (control EtOH) is also
shown. No significant differences were detected by the Friedman test.
4 © 2013 John Wiley & Sons Ltd
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tration present in Tam and 4HO-Tam treatments; this control (Con-
trol EtOH) also did not affect the NHEM viability (Fig. 3).
Oestrogens regulate biological functions by two distinct mecha-
nisms: a classical pathway that involves the binding to nuclear
receptors (ligand-inducible transcription factors) and consequent
regulation of the expression of target genes and a non-classical
pathway that begins with the oestrogen binding to a membrane
receptor followed by rapid intracellular signalling cascades that can
eventually lead to gene transcription regulation. In normal human
cutaneous melanocytes, the presence of classical oestrogen recep-
tors has been demonstrated by binding studies and using immuno-
cytochemistry and RT-PCR [6, 18]. Although SERMs may act
through alternative mechanisms not involving the oestrogen recep-
tor binding, to better elucidate their biological impact, the tran-
script level of genes of interest should be monitored [19, 20]. The
expression of melanogenesis-related genes is crucial to the synthesis
of pigments. Hence, in this work, the outcome after 72 h of Tam
and 4HO-Tam treatment on transcription of melanogenesis-related
genes in NHEM was evaluated by real-time PCR (Fig. 4). These
genes were identified in a microarray study by us (unpublished) as
being the most expressed in pigmented vs. grey hair follicles. In
NHEM, after 72 h of treatment, 4HO-Tam in particular up-regu-
lated melanogenesis-related genes transcription even after melanin
extrusion peak at 24 h. Even so, the fold change in TYR mRNA
induced by 4HO-Tam is in the range described by Kippenberger
et al. [21], after treating normal human melanocytes with 20 lM
oestradiol for 48 h. Considering the control 0.1% ethanol (control
EtOH), the effect of 4HO-Tam and, to a lesser extent, the effect of
Tam were more pronounced for SILV and MLANA genes. PMEL17,
also known as gp100 or SILV, is a structural protein essential for
the transition from stage I to stage II melanosomes. After its deliv-
ery to stage I melanosomes, PMEL17 is cleaved into several frag-
ments, which form the fibrillar matrix of the organelle [22]. In
pigmented cells, melanins are deposited on these protein fibres,
resulting in a progressively pigmented internal matrix. MART-1,
codified by MLANA gene, forms a complex with PMEL17 and
affects its post-transcriptional production, stability, trafficking and
processing [23]. 4HO-Tam and Tam affect in particular these two
genes involved in the early maturation of melanosomes. Despite
the absence of known diseases associated with these genes, it is
possible that some forms of albinism may be linked to PMEL17 defi-
ciency by analogy to the mouse silver mutant [24]. Eventually,
these SERMs may be a good starting point for future investigation
on therapeutic treatment in heterozygosis disorders involving
PMEL17 or MART-1.
To further understand the possible mechanism of action of 4HO-
Tam and Tam in NHEM, the levels of cAMP, a key messenger in
melanogenesis, were determined (Fig. 5). The solvent and both
Tam and 4HO-Tam significantly decreased the levels of intracellu-
Figure 4 Relative expression of melanogenesis-related genes normalized to
transcript levels of housekeeping gene mitochondrial ATPase 6 in NHEM
after 72 h of incubation with tamoxifen (Tam) and 4-hydroxy-tamoxifen
(4HO-Tam), determined by real-time PCR using the DDCt method. The effect
of the solvent alone (control EtOH) is also shown. No significant differences
were detected by the Kruskal–Wallis H-test.
Figure 5 Levels of intracellular cyclic adenosine monophosphate (cAMP) in
NHEM after 72 h of incubation with tamoxifen (Tam) and 4-hydroxy-tamox-
ifen (4HO-Tam). The effect of the solvent alone (control EtOH) is also shown.
Averages that do not share a letter are significantly different according to
Kruskal–Wallis H-test (H = 22.48; DF = 3; P < 0.001) followed by Mann–
Whitney U-test as post-hoc test.
Figure 6 Relative gene expression of catalase normalized to transcript levels
of housekeeping gene mitochondrial ATPase 6 in NHEM after 72 h of incu-
bation with tamoxifen (Tam) and 4-hydroxy-tamoxifen (4HO-Tam), deter-
mined by real-time PCR using the DDCt method. The effect of the solvent
alone (control EtOH) is also shown. Averages that do not share a letter are
significantly different according to Kruskal–Wallis H-test (H = 6.51; DF = 2;
P = 0.039) followed by Mann–Whitney U-test as post-hoc test.
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lar cAMP. The results have shown that after 72 h, the levels of
cAMP are negatively correlated with the levels of intracellular mel-
anin, indicating that the chosen time window, although revealing
significant changes in melanin content, did not support the notion
that the mechanism of action involves elevation of cAMP levels. In
melanocytes, the cAMP/CREB signalling pathway is regulated by
melanocyte-stimulating hormone via the G-protein-coupled receptor
MC1R, which in turn transcriptionally activates expression of
MITF, the master transcriptional regulator of melanocyte develop-
ment [25]. In vitro and in vivo, the up-regulation of cAMP levels in
melanocytes leads to increased pigment production. The magnitude
and duration of cAMP action are regulated by both production and
hydrolysis. MITF directly regulates the transcription of the phos-
phodiesterase 4D3, creating negative homoeostatic control of the
cAMP pathway to counteract chronic stimulation of the cAMP
pathway in melanocytes [26]. Fast response to oestrogens is attrib-
uted to membrane oestrogen receptors that trigger rapid increases
in cAMP, calcium, extracellular signal-regulated kinase (ERK), sig-
nalling pathways all involved in melanogenesis regulation [27].
Tamoxifen and 4HO-Tam are able to bind to G-coupled membrane
oestrogen receptor possessing also a non-genomic mechanism of
action as oestrogen agonists [28–31].
Melanin synthesis generates hydrogen peroxide (H2O2) and other
free radicals making oxidative stress a common theme in melano-
cyte dysfunction especially relevant for the hair follicle melanocyte
population [32]. It was shown in vivo that human grey/white scalp
hair shafts accumulate H2O2 in millimolar concentrations [33].
Melanocytes are sensitive to reactive oxygen species (ROS) due to
low catalase levels in these cells. Kauser et al. [34] verified that cat-
alase expression was reduced both in epidermal and hair follicle
melanocytes with age, whereas superoxide dismutases remain con-
stant. The outcome of H2O2 accumulation in melanocytes depends
on its concentration [35, 36]. Millimolar concentrations of H2O2
can damage many proteins and peptides leading to deactivation/
disruption of many important pathways involved in melanogenesis.
However, tyrosinase as well as other proteins are up-regulated and
activated by low concentrations of H2O2 [35]. Consequently, cata-
lase expression/activity is getting increasing attention as a key
point for the response of melanocytes to ROS. In human melano-
cytes in vitro, catalase-specific mRNA, protein and enzymatic activ-
ity were directly correlated with total cellular melanin content
[37]. Because tamoxifen was described as up-regulating catalase
gene transcription and catalase production in aorta of rats after
one and two weeks of treatment [38], the influence of Tam and
4HO-Tam on CAT gene mRNA levels of NHEM was determined by
real-time PCR (Fig. 6). The levels of CAT mRNA in NHEM were sig-
nificantly higher upon treatment with 4HO-Tam. Tam and ethanol
also induced to some extent the transcription of CAT. A correlation
between the up-regulation of CAT transcript levels and intracellular
melanin induced by physiological concentrations of the two SERMs
tested was verified. Some controversy exists in the literature regard-
ing the putative anti-oxidant role of oestrogens and tamoxifen.
Tam promotes superoxide production in platelets increasing the
thrombosis risk factor [39], and others describe Tam as being able
to reduce the Mn-induced ROS formation in astrocytes [28]. The
mechanism must be dependent on the cell type and context; how-
ever, if SERMs induce ROS production, they can, depending on the
ROS concentrations, activate cellular defensive mechanisms or
induce oxidative stress. Under the conditions tested, the 4HO-Tam
and Tam at physiological concentrations induced catalase expres-
sion in NHEM pointing towards a promelanogenic effect mediated
by ROS.
Concluding remarks
Based on current knowledge on the beneficial effects of topical
application of SERMs on skin ageing, there are still many open
questions concerning safety, secondary effects and mechanisms of
action. The work here reported demonstrated that Tam and its
potent metabolite, 4HO-Tam, have the capacity to induce melanin
production and extrusion in normal human melanocytes in vitro,
not showing cytotoxicity at physiological concentrations. Melanin
itself is a defensive mechanism from photodamage, but uneven pig-
mentation is undesirable; therefore, further studies must be per-
formed to exclude this hypothesis for topical application of SERMs.
The complexity of melanogenesis regulation, which is evident in
this work along with other published reports, makes this biological
process very hard to modulate exogenously. The mechanism by
which these two SERMs act involves changes at the transcript lev-
els of important proteins in the early maturation of melanosomes,
PMEL17 and MART-1, and in a newly recognized key melanogene-
sis modulator – catalase. The capacity of inducing anti-oxidant
defensive mechanisms is clearly an advantage of these SERMs from
the point of view of an anti-ageing cosmetic use. Our results sug-
gested a possible application of SERMs as non-toxic, anti-oxidant
and melanogenic compounds to be used in topic formulations in
cosmetic industry.
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